TY - JOUR
T1 - Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years
T2 - an analysis of the Global Burden of Disease Study 2017
AU - GBD 2017 Diarrhoeal Disease Collaborators
AU - Troeger, Christopher E.
AU - Khalil, Ibrahim A.
AU - Blacker, Brigette F.
AU - Biehl, Molly H.
AU - Albertson, Samuel B.
AU - Zimsen, Stephanie R.M.
AU - Rao, Puja C.
AU - Abate, Degu
AU - Ahmadi, Alireza
AU - Ahmed, Mohamed Lemine Cheikh brahim
AU - Akal, Chalachew Genet
AU - Alahdab, Fares
AU - Alam, Noore
AU - Alene, Kefyalew Addis
AU - Alipour, Vahid
AU - Aljunid, Syed Mohamed
AU - Al-Raddadi, Rajaa M.
AU - Alvis-Guzman, Nelson
AU - Amini, Saeed
AU - Anber, Nahla Hamed
AU - Anjomshoa, Mina
AU - Antonio, Carl Abelardo T.
AU - Arabloo, Jalal
AU - Aremu, Olatunde
AU - Atalay, Hagos Tasew
AU - Atique, Suleman
AU - Avokpaho, Euripide F.G.A.
AU - Awad, Samah
AU - Awasthi, Ashish
AU - Badawi, Alaa
AU - Balakrishnan, Kalpana
AU - Banoub, Joseph Adel Mattar
AU - Barac, Aleksandra
AU - Bassat, Quique
AU - Bedi, Neeraj
AU - Bennett, Derrick A.
AU - Bhattacharyya, Krittika
AU - Bhutta, Zulfiqar A.
AU - Bijani, Ali
AU - Car, Josip
AU - Carvalho, Félix
AU - Castañeda-Orjuela, Carlos A.
AU - Christopher, Devasahayam J.
AU - Dandona, Lalit
AU - Dandona, Rakhi
AU - Daryani, Ahmad
AU - Demeke, Feleke Mekonnen
AU - Deshpande, Aniruddha
AU - Djalalinia, Shirin
AU - Dubey, Manisha
N1 - Funding Information:
SMA acknowledges the International Centre for Casemix and Clinical Coding, Faculty of Medicine, National University of Malaysia and Department of Health Policy and Management, Faculty of Public Health, Kuwait University for their approval and support to participate in this research project. AsA acknowledges funding support from the Department of Science and Technology, Government of India through the INSPIRE faculty scheme. AlaB acknowledges support from the Public Health Agency of Canada. AleB acknowledges support for research from the Project of Ministry of Education, Science and Technology of the Republic of Serbia ( number III45005 ). FC acknowledges funding support from Foundation for Science and Technology/Minister of Science, Technology, and Higher Education through national funds ( UID/MULTI/04378/2019 and UID/QUI/50006/2019 ). AMS was supported by the Egyptian Fulbright Mission Program. MMSM acknowledges the support from the Ministry of Education, Science and Technological Development, Republic of Serbia ( Contract No. 175087 ). AS acknowledges support from Health Data Research UK. Editorial note: The Lancet Group takes a neutral position with respect to territorial claims in published maps and institutional affiliations.
Funding Information:
SLJ reports grants from Sanofi Pasteur during the conduct of the study. MJP reports grants from Asc Academics, AstraZeneca, Bayer, BioMerieux, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, IQVIA, Merck Sharp & Dohme, Novavax, Pfizer, and Sanofi; personal fees from Asc Academics, Astra Zeneca, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Ingress Health, IQVIA, Merck Sharp & Dohme, Novartis, Novavax, Pharmerit, Pfizer, Quintiles, and Sanofi; non-financial support Asc Academics; owning 2% of Ingress Health stocks and 100% of Pharmacoeconomics Advice Groningen stocks; and acting as advisor for Asc Academics outside of the submitted work. All other authors declare no competing interests.
Publisher Copyright:
© 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
PY - 2020/1
Y1 - 2020/1
UR - http://www.scopus.com/inward/record.url?scp=85076157849&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076157849&partnerID=8YFLogxK
U2 - 10.1016/S1473-3099(19)30401-3
DO - 10.1016/S1473-3099(19)30401-3
M3 - Article
C2 - 31678029
AN - SCOPUS:85076157849
SN - 1473-3099
VL - 20
SP - 37
EP - 59
JO - The Lancet Infectious Diseases
JF - The Lancet Infectious Diseases
IS - 1
ER -